Broadfoot Jill Marie
Insider CIK 1305178 · LIFE Chief Financial Officer · ACRX Director · OTIC Director · CUE Director · VICL Sr Vice President, CFO, Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | A Award deriv | 2026-06-22 | 2026-06-24 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2026-06-22 | 2026-06-24 | 5,100 | — | $0 | 13,647 | SEC↗ |
| ATYR aTYR PHARMA INC | S Sale | 2026-02-04 | 2026-02-04 | 1,558 | $0.98 | $1.5K | 37,296 | SEC↗ |
| ATYR aTYR PHARMA INC | M Exercise deriv | 2026-02-03 | 2026-02-04 | 3,750 | — | $0 | 0 | SEC↗ |
| ATYR aTYR PHARMA INC | M Exercise | 2026-02-03 | 2026-02-04 | 3,750 | — | $0 | 38,854 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2026-01-09 | 2026-01-09 | 412,500 | — | $0 | 412,500 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-10-23 | 2025-10-24 | 25,600 | — | $0 | 25,600 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-10-23 | 2025-10-24 | 4,267 | — | $0 | 8,547 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 48,800 | — | $0 | 48,800 | SEC↗ |
| ATYR aTYR PHARMA INC | S Sale | 2025-02-04 | 2025-02-04 | 1,254 | $3.78 | $4.7K | 31,763 | SEC↗ |
| ATYR aTYR PHARMA INC | M Exercise deriv | 2025-02-03 | 2025-02-04 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ATYR aTYR PHARMA INC | M Exercise | 2025-02-03 | 2025-02-04 | 3,750 | — | $0 | 33,017 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2025-01-08 | 2025-01-10 | 275,000 | — | $0 | 275,000 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2024-06-24 | 2024-06-24 | 13,044 | — | $0 | 13,044 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2024-06-24 | 2024-06-24 | 2,174 | — | $0 | 4,280 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2024-05-31 | 2024-06-03 | 5,000 | $1.79 | $8.9K | 27,960 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2024-02-06 | 2024-02-06 | 1,590 | $1.69 | $2.7K | 20,821 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2024-02-05 | 2024-02-06 | 3,750 | — | $0 | 7,500 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2024-02-05 | 2024-02-06 | 3,750 | — | $0 | 22,411 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2024-01-05 | 2024-01-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2023-10-10 | 2023-12-13 | 3,487 | — | $0 | 3,487 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2023-10-10 | 2023-12-13 | 581 | — | $0 | 2,106 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2023-02-16 | 2023-02-21 | 84,023 | — | $0 | 84,023 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2023-02-06 | 2023-02-06 | 1,566 | $2.36 | $3.7K | 15,460 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2023-02-03 | 2023-02-06 | 3,750 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2023-02-03 | 2023-02-06 | 3,750 | — | $0 | 17,026 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2022-07-15 | 2022-07-15 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2022-07-15 | 2022-07-15 | 15,500 | — | $0 | 30,500 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2022-06-21 | 2022-06-23 | 27,500 | — | $0 | 27,500 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-05-24 | 2022-05-26 | 75,347 | — | $0 | 75,347 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-02-03 | 2022-02-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-02-03 | 2022-02-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2022-01-13 | 2022-01-18 | 1,923 | $6.75 | $13.0K | 12,112 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-11-20 | 2021-11-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2021-11-20 | 2021-11-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OTIC OTONOMY, INC. | A Award deriv | 2021-08-18 | 2021-08-20 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-05-21 | 2021-05-25 | 54,000 | — | $0 | 54,000 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2021-02-09 | 2021-02-09 | 390 | $7.66 | $3.0K | 9,833 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2021-02-06 | 2021-02-09 | 892 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2021-02-06 | 2021-02-09 | 892 | — | $0 | 10,223 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-02-04 | 2021-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2020-06-19 | 2020-06-23 | 1,850 | $4.22 | $7.8K | 9,153 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-26 | 2020-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-02-07 | 2020-02-07 | 375 | $4.03 | $1.5K | 7,125 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2020-02-06 | 2020-02-07 | 893 | — | $0 | 893 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2020-02-06 | 2020-02-07 | 893 | — | $0 | 7,500 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-02-05 | 2020-02-07 | 23,359 | — | $0 | 23,359 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-02-06 | 2019-02-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-02-06 | 2019-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-09-20 | 2018-09-21 | 38,000 | $0.84 | $31.9K | 90,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-09-19 | 2018-09-21 | 26,000 | $0.81 | $21.1K | 52,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-09-14 | 2018-09-18 | 26,000 | $0.73 | $19.0K | 26,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-07-30 | 2018-08-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VICL VICAL INC | F Tax w/h | 2013-04-01 | 2013-04-03 | 38,121 | $3.88 | $147.9K | 145,649 | SEC↗ |
| VICL VICAL INC | F Tax w/h | 2013-01-13 | 2013-01-15 | 2,370 | $3.31 | $7.8K | 232,565 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2013-01-11 | 2013-01-15 | 123,515 | — | $0 | 915,109 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2013-01-11 | 2013-01-15 | 29,594 | — | $0 | 791,594 | SEC↗ |
| VICL VICAL INC | P Buy | 2013-01-11 | 2013-01-15 | 27,060 | $0.01 | $271 | 234,935 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2012-01-13 | 2012-01-18 | 117,125 | — | $0 | 762,000 | SEC↗ |
| VICL VICAL INC | A Award deriv | 2012-01-13 | 2012-01-18 | 29,875 | — | $0 | 644,875 | SEC↗ |
| VICL VICAL INC | P Buy | 2012-01-13 | 2012-01-18 | 27,000 | $0.01 | $270 | 207,875 | SEC↗ |